Programs & Initiatives
In 2020, as Pfizer and BioNTech were still developing the COVID-19 vaccine, Julie Jenson was thinking about how to distribute that vaccine to every country around the world, regardless of that country’s means. Jenson, who is Director of International Product Access for Pfizer’s Global Health and Social Impact Team, knew even in those early days that the ultracold storage demands and shipping requirements of the vaccine could pose challenges in reaching people living in remote areas of low- and...